Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Dana M RoqueEric R SiegelNatalia BuzaStefania BelloneDan-Arin SilasiGloria Shining HuangVaagn AndikyanMitchell ClarkMasoud AzodiPeter E SchwartzGautam G RaoJocelyn C ReaderPei HuiJoan R Tymon-RosarioJustin HaroldDennis MauricioBurak ZeybekGulden MenderesGary AltwergerElena RatnerAlessandro D SantinPublished in: British journal of cancer (2024)